Market Introduction
Intraoperative neuromonitoring (IONM) is an integral part of most of the surgical procedures. It has been widely used minimize neurological morbidity from operative manipulations, identify neural structures and thereby prevent post-operative impairments. The goal of such monitoring is to identify changes in spinal cord, brain, and peripheral nerve function prior to irreversible damage. IONM employs a wide range of modalities, which includes motor evoked potentials (MEPs), somatosensory evoked potentials (SSEPs), electroencephalography (EEG), electromyography, brainstem auditory evoked potentials (BAEPs), and visual evoked potentials (VEPs).
Market Overview and Dynamics
The North America intraoperative neuromonitoring market is expected to reach US$ 1,874.02 million by 2027 from US$ 1,029.17 million in 2019. The market is anticipated to grow at a CAGR of 7.9% during 2019–2027. The rising incidences of neurological disorders and increasing technological advancements in the field of neuromonitoring are the major factors expected to boost the growth of the intraoperative neuromonitoring market in North America. However, the market is likely to get impacted by the risk factor such as dearth of skilled professional during the forecast period.
Key Market Segments
In terms of product, the systems segment accounted for the largest share of the North America intraoperative neuromonitoring market in 2019. In terms of source, insourced monitoring segment accounted for the largest share of the North America intraoperative neuromonitoring market in 2019. In terms of modality, the somatosensory evoked potentials segment accounted for the largest share of the North America intraoperative neuromonitoring market in 2019. In terms of application, the spinal surgery segment accounted for the largest share of the North America intraoperative neuromonitoring market in 2019. In terms of end-user, the hospitals segment accounted for the largest share of the North America intraoperative neuromonitoring market in 2019.
Major Sources and Companies Listed
Several major primary and secondary sources associated with the North America intraoperative neuromonitoring market report are the World Health Organization (WHO), Centers of Disease Control and Prevention (CDC), Orthopaedic Research Society, Canadian Patient Safety Institute (CPSI), and American Association of Neurological Surgeons, among others.
Reasons to buy report
- It provides understanding of the North America, intraoperative neuromonitoring market landscape and identifies intraoperative neuromonitoring market segments that are most likely to guarantee a strong return.
- It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the North America intraoperative neuromonitoring market.
- It helps efficiently plan merger and acquisition, and partnership deals in the intraoperative neuromonitoring market by identifying market segments with the most promising probable sales
- It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of intraoperative neuromonitoring market performance of various segments pertaining to the North America intraoperative neuromonitoring market.
- It provides intraoperative neuromonitoring market revenue forecast of the market based on various segments for the period from 2019 to 2027.
NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET SEGMENTATION
By Product
- Systems
- Accessories
- Services
By Source
- Insourced Monitoring
- Outsourced Monitoring
By Modality
- Motor Evoked Potentials
- Somatosensory Evoked Potentials
- Electroencephalography
- Electromyography
- Brainstem Auditory Evoked Potentials
- Visual Evoked Potentials
By Application
- Spinal Surgery
- Neurosurgery
- Vascular Surgery
- ENT Surgery
- Orthopedic Surgery
- Other Surgeries
By End User
- Hospitals
- Ambulatory Surgical Centers
By Country
- US
- Canada
- Mexico
Company Profiles
- Accurate Monitoring
- Computational Diagnostics, Inc
- IntraNerve Neuroscience Holdings, LLC
- Natus Medical Incorporated
- NuVasive, Inc
- SpecialtyCare
- Moberg Research, Inc
North America Intraoperative Neuromonitoring Market Strategic Insights
North America Intraoperative NeuromonitoringMarket Report Highlights
| Report Attribute | Details |
| Market size in 2019 | US$ 1,029.17 Million |
| Market Size by 2027 | US$ 1,874.02 Million |
| CAGR (2019 - 2027) | 7.9% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Product
|
|
Regions and Countries Covered
|
|
| North America | US, Canada, Mexico |
| Market leaders and key company profiles |
|
North America Intraoperative Neuromonitoring Market Country and Regional Insights
